Evaluación económica de la procalcitonina como guía de la terapia antibiótica para infección respiratoria aguda en adultos en un hospital de referencia en Colombia …

JA Medina Parra - repositorio.unal.edu.co
Introducción: La infección respiratoria aguda representa una alta carga de la enfermedad
para las instituciones hospitalarias, esta patología se asocia a un alto consumo de …

Budget impact analysis of using procalcitonin to optimize antimicrobial treatment for patients with suspected sepsis in the intensive care unit and hospitalized lower …

W Cornistein, O Garay, G Guiñazú - 2021 - riu.austral.edu.ar
Background: Inappropriate antibiotic use represents a major global threat. Sepsis and
bacterial lower respiratory tract infections (LRTIs) have been linked to antimicrobial …

[HTML][HTML] Budget impact analysis of using procalcitonin to optimize antimicrobial treatment for patients with suspected sepsis in the intensive care unit and hospitalized …

OU Garay, G Guiñazú, W Cornistein, J Farina… - Plos one, 2021 - journals.plos.org
Background Inappropriate antibiotic use represents a major global threat. Sepsis and
bacterial lower respiratory tract infections (LRTIs) have been linked to antimicrobial …

Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a Chinese hospital system perspective

I Stojanovic, JE Schneider, L Wei, Z Hong… - Clinical Chemistry and …, 2017 - degruyter.com
Background: Cost-impact models have indicated that in the USA, the use of antibiotic
stewardship protocols based on procalcitonin (PCT) levels for patients with suspected acute …

EE478 Cost-Effectiveness Analysis of Procalcitonin Compared to C-Reactive Protein (CRP) in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease …

JGB Gomez, EV Arbelaez, R Niño… - Value in …, 2023 - valueinhealthjournal.com
Objectives to estimate the cost effectiveness of the tests available for the detection of
bacterial infections in patients diagnosed with chronic obstructive disease (COPD) and …

[HTML][HTML] Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective

P Schuetz, R Balk, M Briel, A Kutz… - Clinical Chemistry and …, 2015 - degruyter.com
Background: Whether or not antibiotic stewardship protocols based on procalcitonin levels
results in cost savings remains unclear. Herein, our objective was to assess the economic …

Procalcitonin-guided use of antibiotics for lower respiratory tract infection

DT Huang, DM Yealy, MR Filbin… - … England Journal of …, 2018 - Mass Medical Soc
Background The effect of procalcitonin-guided use of antibiotics on treatment for suspected
lower respiratory tract infection is unclear. Methods In 14 US hospitals with high adherence …

Procalcitonina en la Unidad de cuidados intensivos como guía terapéutica antimicrobiana en choque séptico no pulmonar

WL Desales - Revista de Medicina e …, 2022 - medicinainvestigacion.uaemex.mx
La procalcitonina, biomarcador sérico que distingue la infección bacteriana de otras causas
de infección, sirviendo como complemento útil para guiar la terapia antimicrobiana y …

Aspectos económicos del uso de procalcitonina

IA Jiménez-Aguilar - Revista Mexicana de Patología Clínica y …, 2017 - medigraphic.com
Los signos clínicos de infecciones en neonatos en estado crítico son poco específicos, lo
que condiciona dificultades para establecer la etiología de la respuesta inflamatoria …

Procalcitonin-guided antibiotic therapy algorithms for different types of acute respiratory infections based on previous trials

P Schuetz, R Bolliger, M Merker… - Expert review of anti …, 2018 - Taylor & Francis
Introduction: Although evidence indicates that use of procalcitonin to guide antibiotic
decisions for the treatment of acute respiratory infections (ARI) decreases antibiotic …